. "In the past decade, it has been realized that rather than a single entity, breast cancer represents a spectrum of neoplastic disorders affecting the same organ (1-4). The expression of human epidermal growth factor receptor-2 (HER-2) is characteristic of subtype(s) of breast cancer with an unfavorable prognosis."@en . "[DA5452AF5FC4]" . . "15110" . "1" . "Melichar, Bohuslav" . "lapatinib; docetaxel; capecitabine; plus; antibody; efficacy; expression; trastuzumab; adjuvant chemotherapy; metastatic breast-cancer"@en . . "In the past decade, it has been realized that rather than a single entity, breast cancer represents a spectrum of neoplastic disorders affecting the same organ (1-4). The expression of human epidermal growth factor receptor-2 (HER-2) is characteristic of subtype(s) of breast cancer with an unfavorable prognosis." . "DE - Spolkov\u00E1 republika N\u011Bmecko" . "RIV/61989592:15110/12:33140631!RIV13-MSM-15110___" . "1434-6621" . . "Targeted therapy for HER-2: personalized medicine for her, too"@en . "2"^^ . . . . . . "Plebani, Mario" . . "1"^^ . . . "Clinical Chemistry and Laboratory Medicine" . "I" . "50" . . "10.1515/CCLM.2011.724" . . . "Targeted therapy for HER-2: personalized medicine for her, too" . . . . . "Targeted therapy for HER-2: personalized medicine for her, too"@en . "Targeted therapy for HER-2: personalized medicine for her, too" . . "173266" . . . "4"^^ . "RIV/61989592:15110/12:33140631" .